Sofosbuvir and Velpatasvir for the Treatment of Hepatitis C Virus in Patients Coinfected With Human Immunodeficiency Virus Type 1: An Open-Label, Phase 3 Study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
2017
https://researcherprofiles.org/profile/1210305
28369210